scorecardresearch
Add as a preferred source on Google
Monday, November 3, 2025
TopicZydus Cadila

Topic: Zydus Cadila

India’s ZyCoV-D set to become world’s first DNA Covid vaccine as govt approval likely soon

Gujarat-based Zydus Cadila has told Modi govt that it could apply for emergency use authorisation for ZyCoV-D vaccine in the next 10-12 days.

Zydus Cadila gets nod for clinical trials of monoclonal antibodies cocktail to treat Covid

Zydus said that its biological therapy ZRC-3308, a cocktail of two SARS-CoV-2-neutralising monoclonal antibodies (mAbs) can emerge as one of the main treatments for mild Covid.

Zydus’s antiviral drug Virafin gets emergency approval to treat moderate Covid patients

In statement, Zydus Cadila says phase 3 clinical trial data showed Virafin reduced oxygen requirement in patients, & and that a significant number of them tested negative by 7th day.

Indian pharma firms Zydus, Alembic recall 2 drugs in US over ‘life-threatening’ consequences

Zydus Cadila recalls injection for treatment of herpes infections over complaints of crystallisation in vials, Alembic Pharmaceuticals recalls its high BP drug due to labelling error.

Off The Cuff with Dr Randeep Guleria

Randeep Guleria, Director, All India Institute of Medical Sciences, New Delhi, was the guest at this edition of ThePrint's Off the Cuff. In a conversation...

On Camera

A fitting tribute to Pakistan’s General Shanti

Durrani as NSA was a leap for Pakistan. No surprise that he didn’t even last a year in that job. He chafed after 26/11, seeing it as a deliberate Army/ISI betrayal.

Consumer Price Index gets up to date. Airfare, OTT plans, e-commerce prices in new basket—MoSPI secy

New CPI series will take 2024 as base year, will provide more accurate measure of inflation, spending on digital services. Expected to enhance representation and reliability, says Saurabh Garg.

Joint production, closer ties, emerging tech: The foundation of new defence pact between India & US

The agreement, signed after meeting between Rajnath and US Secretary of War Pete Hegseth on sidelines of ADMM-Plus in Kuala Lumpur, aims to deepen bilateral ties in the critical sector.

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.